His main research concerns Renal cell carcinoma, Carcinoma, Surgery, Internal medicine and Nephrectomy. His Renal cell carcinoma study combines topics from a wide range of disciplines, such as Cancer, Kidney disease and Urology. His Carcinoma research integrates issues from Clinical trial, Adenocarcinoma, Natural history, Survival analysis and Risk factor.
Allan J. Pantuck combines subjects such as Prostate-specific antigen, Prostate and Prostate cancer with his study of Surgery. His biological study deals with issues like Oncology, which deal with fields such as Univariate analysis. Allan J. Pantuck interconnects Epidemiology, Predictive value of tests, Retrospective cohort study, Proportional hazards model and Prospective cohort study in the investigation of issues within Nephrectomy.
Allan J. Pantuck mainly investigates Renal cell carcinoma, Internal medicine, Oncology, Pathology and Nephrectomy. His research in Renal cell carcinoma intersects with topics in Carcinoma, Surgery, Kidney disease and Urology. The concepts of his Carcinoma study are interwoven with issues in Survival rate, Survival analysis and Performance status.
His is doing research in Nephrology, Cancer, Prostate cancer, Stage and Clear cell renal cell carcinoma, both of which are found in Internal medicine. His Oncology study incorporates themes from Hazard ratio, Clinical trial and Immunotherapy. His study with Nephrectomy involves better knowledge in Kidney.
Allan J. Pantuck mostly deals with Internal medicine, Renal cell carcinoma, Oncology, Prostate cancer and Cancer. Allan J. Pantuck focuses mostly in the field of Internal medicine, narrowing it down to matters related to Placebo and, in some cases, Gastroenterology, Randomized controlled trial and Survival rate. The study incorporates disciplines such as Carcinoma and Nephrectomy in addition to Renal cell carcinoma.
His Nephrectomy research incorporates elements of Surgery and Clinical significance. In the field of Oncology, his study on Kidney cancer overlaps with subjects such as TRAC. His studies deal with areas such as Logistic regression, Proportional hazards model, Propensity score matching and Urology as well as Cancer.
Allan J. Pantuck spends much of his time researching Internal medicine, Renal cell carcinoma, Oncology, Surgery and Urology. His work deals with themes such as Placebo and Chromosome, which intersect with Internal medicine. His study in Renal cell carcinoma is interdisciplinary in nature, drawing from both Adjuvant, Carcinoma, Proportional hazards model and Nephrectomy.
His study on Oncology also encompasses disciplines like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Charles J. Ryan;Matthew R. Smith;Johann S. De Bono;Arturo Molina.
The New England Journal of Medicine (2013)
THE CHANGING NATURAL HISTORY OF RENAL CELL CARCINOMA
Allan J. Pantuck;Amnon Zisman;Arie S. Belldegrun.
The Journal of Urology (2001)
Improved Prognostication of Renal Cell Carcinoma Using an Integrated Staging System
Amnon Zisman;Allan J. Pantuck;Fredrick Dorey;Jonathan W. Said.
Journal of Clinical Oncology (2001)
Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience
Jean Jacques Patard;Emmanuelle Leray;Nathalie Rioux-Leclercq;Luca Cindolo.
Journal of Clinical Oncology (2005)
Risk Group Assessment and Clinical Outcome Algorithm to Predict the Natural History of Patients With Surgically Resected Renal Cell Carcinoma
Amnon Zisman;Allan J. Pantuck;Jeffery Wieder;Debby H. Chao.
Journal of Clinical Oncology (2002)
Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: Implications for prognosis and therapy
Matthew H.T. Bui;David Seligson;Ken ryu Han;Allan J. Pantuck.
Clinical Cancer Research (2003)
SAFETY AND EFFICACY OF PARTIAL NEPHRECTOMY FOR ALL T1 TUMORS BASED ON AN INTERNATIONAL MULTICENTER EXPERIENCE
Jean-Jacques Patard;Oleg Shvarts;John S. Lam;Allan J. Pantuck.
The Journal of Urology (2004)
Carbonic Anhydrase IX Is an Independent Predictor of Survival in Advanced Renal Clear Cell Carcinoma
Matthew H. T. Bui;David Seligson;Ken-ryu Han;Allan J. Pantuck.
American Association for Cancer Research (2003)
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy
Alain Ravaud;Robert J. Motzer;Hardev S. Pandha;Daniel J. George.
The New England Journal of Medicine (2016)
Phase II Study of Pomegranate Juice for Men with Rising Prostate-Specific Antigen following Surgery or Radiation for Prostate Cancer
Allan J. Pantuck;John T. Leppert;Nazy Zomorodian;William Aronson.
Clinical Cancer Research (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: